<DOC>
	<DOCNO>NCT02278588</DOCNO>
	<brief_summary>In investigator-initiated study , compare change brain cognitive biomarkers assess diffusion tensor image 2.5 year among 12 patient Idiopathic Parkinson 's disease ( IPD ) receive rasagiline , 20 IPD patient receive MAO-B inhibitor 25 age-matched healthy control . Will also compare change Mini-Mental State Exam ( MMSE ) Montreal Cognitive Assessment ( MoCA ) score plasma brain-derived neurotrophic factor ( BDNF ) change brain cognitive biomarkers IPD patient HC 2.5 year .</brief_summary>
	<brief_title>Effect 2.5 Years Rasagiline Therapy Progression Cognitive Biomarkers Assessed MRI Parkinson 's Disease .</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Rasagiline</mesh_term>
	<criteria>IPD HC subject enrol similar study 2.5 year ago Baseline DTI data available .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>